CancerX Moonshot

This week, representatives from the 150+ CancerX member organizations gathered for our annual member meeting and convened with federal representatives. CancerX members were met with opening remarks from Maureen Clark Szemborski, Senior Advisor on Cancer, The White House, Office of the First Lady (OFL), on harnessing the full power of #digitalinnovation to support every activity in pursuit of the Cancer Moonshot. During our annual meeting, CancerX members worked together on the following: ▪ Establishing areas of unmet need in cancer research and care that digital health solutions could address  ▪ Generating concepts to inform projects and accelerator activities that leverage digital innovations ▪ Facilitating opportunities for collaborations within the CancerX community and federal representatives It’s not too late to join us as we continue to promote more equitable access and treatment for all who are impacted by #cancer. Learn more about joining CancerX here: cancerx.health #CancerXSummit2024 Digital Medicine Society (DiMe), Moffitt Cancer Center, Assistant Secretary for Technology Policy and Office of the Assistant Secretary for Health (OASH)

We are proud to continue our collaboration with Moffitt Cancer Center as host of CancerX in partnership with the Assistant Secretary for Technology Policy (ASTP) and Office of the National Coordinator for Health Information Technology (ONC), driving digital innovation in cancer care. We're excited to expand CancerX's impact in year two and beyond with the upcoming launch of the CancerX Accelerator at HLTH USA 2024 and exclusive member events. Stay tuned for updates at HLTH 2024! #CancerX #Moffitt #DigitalHealth #CancerInnovation #HLTH2024

With cost being the single most significant barrier for #healthsystems investing in patient navigation programming, CancerX’s Digital Navigation ROI Calculator and CancerX Digitally Enabled Patient Navigation Blueprint are helping health systems measure and optimize the ROI of their investments in digitally enabled patient navigation. These resources are unlocking the promise of #digitalinnovation to minimize disparities in cancer care access and out-of-pocket cost measures associated with cancer, ensuring that financial worries do not overshadow the fight for recovery. By measuring and optimizing the ROI of investments in digitally enabled patient navigation, these resources are helping health systems and directly impacting patient access, cost, and health outcomes. Cate OReilly of Cancer Support Community joined our public launch event and discussed how digital solutions contribute to patient outcomes and give providers the tools they need. Access the resources: https://lnkd.in/ekc9Z37b

👏 Exciting news from the Clinical Pathways Congress + Cancer Care Business Exchange in Boston! Sarah Sheehan, CancerX Program Lead at Digital Medicine Society (DiMe), Shruti Iyer from Oracle Health and Manasi Kapoor from Memorial Sloan Kettering Cancer Center shared insights on the recently released CancerX resources. The group discussed how these resources can be deployed to support health system decision-making and digitally enabled patient navigation, integrating seamlessly with existing EMR platforms and new payment pathways. They also discussed what’s ahead for CancerX, including the opening of accelerator applications for the 2025 cohort. A big thank you to everyone who joined the session. Check out these photos from the event!

📅 Tomorrow is the day! Sarah Sheehan will be representing CancerX at the Cancer Care Business Exchange in Boston, presenting on the latest developments, progress, and initiatives at CancerX. This session will highlight how CancerX is driving innovation and collaboration in cancer care, showcasing the consortium's contributions to advancing patient outcomes and healthcare delivery. Don’t miss out—register now with code VIP for 15% off! https://bit.ly/3Xhlg8t Clinical Pathways Congress + Cancer Care Business Exchange Digital Medicine Society (DiMe)

Today, representatives from the 150+ CancerX member organizations gathered for our annual member meeting. They convened with federal representatives to share cancer priorities and align the CancerX mission, goals, and vision for #digitalinnovation for the year ahead. The resultant CancerX priorities and activities coming from this meeting target outsized impact through knowledge exchange and collaboration by: ▪️Establishing areas of unmet need in #cancer research and care that digital health solutions can address ▪️Generating concepts to inform projects and accelerator activities that leverage digital innovations ▪️Facilitating opportunities for collaboration within the CancerX community and federal representatives And this is just the beginning! Stay tuned for what’s next from CancerX by signing up for our newsletter: https://lnkd.in/eesphEc2 #CancerXSummit2024 Digital Medicine Society (DiMe) Moffitt Cancer Center Assistant Secretary for Technology Policy and Office of the Assistant Secretary for Health (OASH)

🚀 The CancerX Digital Navigation ROI Calculator and Digitally Enabled Patient Navigation Blueprint provide patient navigators with the tools they need to develop a business case and implementation strategy for standardized, scalable, and sustainable #patient navigation programming. These resources prove the value of investing in #digital navigation programming to reduce patient financial toxicity, which impacts consistent appointment attendance, treatment plan adherence, access to necessary medications, and, ultimately, survival outcomes. Are you interested in learning how these resources quantify and optimize the return on investment (ROI) for health systems that embrace digitally infused patient navigation programming? Hear how Danielle Brown of Florida Cancer Specialists & Research Institute uses these resources to ensure patients receive the care they need and deserve. Access the resources: https://lnkd.in/ekc9Z37b

🚨 The Cancer Care Business Exchange in Boston is just around the corner, and we’re thrilled that Sarah Sheehan, CancerX Program Lead at Digital Medicine Society (DiMe), will be presenting on September 6, 2024. Sarah’s session will provide an update on the latest developments, progress, and initiatives at CancerX, highlighting its role in driving innovation and collaboration in the field of cancer research and care. Join us to learn how CancerX is making a real impact in advancing patient outcomes and transforming healthcare delivery. 🔗 Register today with code VIP for 15% off! https://lnkd.in/e2UiyJa5 Clinical Pathways Congress + Cancer Care Business Exchange

🌟 We’re excited to announce that Sarah Sheehan, CancerX Program Lead at Digital Medicine Society (DiMe), will speak at the Cancer Care Business Exchange in Boston on Sept. 6, 2024! Sarah will provide an update on the latest developments, progress, and initiatives at CancerX, highlighting its role in driving innovation and collaboration in the field of cancer research and care. Whether you’re a professional in oncology or simply passionate about advancing healthcare, this session will showcase how CancerX is contributing to better patient outcomes and healthcare delivery. Use code VIP for 15% off your registration! https://bit.ly/3Xhlg8t Clinical Pathways Congress + Cancer Care Business Exchange

Have you checked out the latest resources from CancerX? 🚀 Yesterday, we were thrilled to launch the Digital Navigation ROI Calculator and the Digitally Enabled Patient Navigation Blueprint to quantify and optimize the return on investment (ROI) for health systems that embrace digitally enabled patient navigation programming. 🎥 We were joined by industry leaders - including Anabella Aspiras from The White House - who discussed how these resources prove the value of investing in #digital navigation programming to reduce patient #financial toxicity and, ultimately, impact survival outcomes. In case you missed the event or would like to refer back to our discussion, you can access the recording of our public launch event here: https://lnkd.in/dv529EJN CancerX is committed to reducing #cancer-related mortality rates and enhancing the quality of life for patients and their families through digital innovation. By empowering and supporting more patient navigators within health and provider systems, these resources directly contribute to improving patient outcomes. Access the resources: https://lnkd.in/ekc9Z37b American Cancer Society Biofourmis Blue Note Therapeutics Cancer Support Community City of Hope Current Health Family Reach Folia Health: The Home-Reported Outcomes Company Genomate Health Kaiser Permanente The Leukemia & Lymphoma Society Lightship Memorial Sloan Kettering Cancer Center Our National Conversation (ONC) Oracle Pluto Health Science 37 Sidekick Health Takeda Digital Ventures Tempus AI Touch, The Black Breast Cancer Alliance U.S. Department of Veterans Affairs